Sterling Clinical Research Inc

Cincinnati, Ohio 45219

We've found

1 trials

at this facility

Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia

Status: Enrolling, Phase II
Updated: 8/21/2015

from

Cincinnati, OH

Use our guide to learn which trials are right for you!